Literature DB >> 28372478

Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine.

Steven P Vickers1, Simon Goddard1, Richard J Brammer1, Peter H Hutson2,3, David J Heal1.   

Abstract

Freely-fed, female, rats were trained in a two-lever, delay-discounting task: one lever delivered a single chocolate-flavoured pellet immediately and the other a three-pellet reward after increasing delay (0, 4, 8, 16, 32 s). Rats were divided into two groups (i.e. binge-eating rats given irregular, limited access to chocolate in addition to normal chow and controls maintained on normal chow). Both groups exhibited increased preference for the immediate reward as the delay interval was lengthened. The discounting rate was significantly greater in binge-eating rats than non-binge-eating controls, especially as the behaviour became more established indicating that increased impulsivity and intolerance of delayed reward are part of the psychopathology of binge-eating. Lisdexamfetamine (0.8 mg/kg, orally ( d-amphetamine base)) reversed the reduced preference of binge-eating rats for larger rewards at delay intervals of 4 s, 8 s and 32 s and across all sessions. Lisdexamfetamine-treated binge-eating rats consumed the same number of pellets as vehicle-treated, binge-eating rats and non-binge-eating controls eliminating the possibility lisdexamfetamine's actions on appetite or satiety mediated its effects on operant responding for food pellets in delay-discounting. In summary, binge-eating rats showed increased impulsive choice compared with non-binge-eating controls that was reversed by lisdexamfetamine, complementing results showing lisdexamfetamine reduced impulsiveness scores in patients with binge-eating disorder.

Entities:  

Keywords:  Lisdexamfetamine; binge-eating; delay-discounting; impulsivity

Mesh:

Substances:

Year:  2017        PMID: 28372478     DOI: 10.1177/0269881117691672

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  9 in total

Review 1.  Lisdexamfetamine: A Review in Binge Eating Disorder.

Authors:  Young-A Heo; Sean T Duggan
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

Review 2.  Emerging Treatments in Eating Disorders.

Authors:  Michael Lutter
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 3.  The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics.

Authors:  Rebecca G Boswell; Marc N Potenza; Carlos M Grilo
Journal:  Clin Ther       Date:  2020-11-27       Impact factor: 3.393

Review 4.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

Review 5.  Food Addiction and Binge Eating: Lessons Learned from Animal Models.

Authors:  Marta G Novelle; Carlos Diéguez
Journal:  Nutrients       Date:  2018-01-11       Impact factor: 5.717

Review 6.  Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward.

Authors:  Catherine F Moore; Valentina Sabino; Pietro Cottone
Journal:  Front Pharmacol       Date:  2018-02-27       Impact factor: 5.810

7.  Machine Learning Based Classification of Deep Brain Stimulation Outcomes in a Rat Model of Binge Eating Using Ventral Striatal Oscillations.

Authors:  Wilder T Doucette; Lucas Dwiel; Jared E Boyce; Amanda A Simon; Jibran Y Khokhar; Alan I Green
Journal:  Front Psychiatry       Date:  2018-08-03       Impact factor: 4.157

8.  The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study.

Authors:  Elizabeth Schneider; Elizabeth Martin; Pia Rotshtein; Kasim L Qureshi; Samuel R Chamberlain; Maartje S Spetter; Colin T Dourish; Suzanne Higgs
Journal:  Transl Psychiatry       Date:  2022-01-10       Impact factor: 6.222

Review 9.  Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.

Authors:  David J Heal; Sharon L Smith
Journal:  J Psychopharmacol       Date:  2021-07-28       Impact factor: 4.562

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.